Hospice providers are reimbursed a set rate per patient day no matter how little tx they deliver. What could go wrong when care for these vulnerable patients is managed by private equity firms and publicly traded companies that try to maximize short-term profits?
bit.ly/3Z3Qm38
bit.ly/4eBZRw3

1. Psychiatrist, therapist, trainer, supervisor with Lykos studying MDMA-AT. Also doing KAP in private practice.

2. Working on a case report applying the inner-directed therapy model to KAP.

3. Language City by Ross Perlin. Fascinating read about the linguistic history of New York

Curious to see how these turn out!

I post about the complex issues surrounding psychedelic research, education, and policy. Less sensationalism, more nuance.

Hi! I’m a psychiatrist at Harvard and a clinical researcher with MAPS/Lykos building the evidence base for MDMA and psychedelic-assisted therapy, and training the next generation of psychedelic clinicians. I develop psychedelic curricula and teach residents about cross-cultural psychiatry. /

Thanks for organizing this! Please add me to the pack

Thanks for organizing! Please add me to the pack!

Thanks for organizing this! Could you please add me to the group?